On Thursday 7th August 2014 Rachel Rawson Clinical Nurse Specialist at Breast Cancer Care comments on research published in the journal Annals of Oncology into the impact Aspirin has on cancer risk:

“The results of this research show taking Aspirin may reduce the risk of developing the major cancers of the digestive tract i.e. bowel stomach and oesophageal cancer. It does not have the same impact on breast cancer risk.

“A number of studies have shown possible protective effects of Aspirin in relation to breast cancer but further large scale trials are still needed.

“We know that long-term use of Aspirin can cause major side effects such as bleeding from the stomach and peptic ulcers and this is important for any women to remember. Anyone considering long-term use of Aspirin should talk to their GP. Anyone with questions about breast cancer can call our free confidential Helpline on 0808 800 6000”

For media enquiries contact the press team on 020 7960 3463 / 07702901334 or press@breastcancercare.org.uk